{"id":92615,"date":"2016-12-19T16:39:02","date_gmt":"2016-12-19T16:39:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=92615"},"modified":"2016-12-19T16:39:02","modified_gmt":"2016-12-19T16:39:02","slug":"cancertumor-profiling-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cancertumor-profiling-market-size-analysis-trends-report-share-investment-opportunities-and-forecast-to-2022_92615.html","title":{"rendered":"Cancer\/Tumor Profiling Market Size, Analysis, Trends, Report, Share, Investment Opportunities and Forecast to 2022"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Stratistics MRC, one stop shop for all your market research needs.”<\/div>\n<\/div>\n<\/div>\n
According to Stratistics MRC, the Global Cancer\/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. Increasing cases of cancer and the need for therapy are the major factors influencing the market growth.<\/div>\n

Moreover, high investments in R&D, technological developments, and demand for safer medicines are the factors fostering the market growth. However, low awareness among clinicians about options and potential of cancer profiling are the major challenges for this market.<\/span><\/p>\n

Order a copy at
http:\/\/www.strategymrc.com\/report\/cancertumor-profiling-market<\/a>
<\/strong><\/span><\/p>\n

By application, personalized medicines segment leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period.  The growth is attributed by unique characteristics of this segment in examining and prognosis of cancer disease. North America commands the market due to the presence of leading cancer profiling industry leaders. Asia Pacific is expected to witness huge growth due to raising incidence of cancer in this region.<\/span><\/p>\n

Some of the key players in global Cancer\/Tumor profiling market include Agendia Nv, Biotheranostics, Boreal Genomics, Inc., Caris Life Sciences, Genomic Health, Inc., Illumina, Inc., Life Technologies Corporation, Nanostring Technologies, Neogenomics Laboratories, Oncopath Laboratory, Oxford Gene Technology Ltd, Precision Therapeutics, Inc., Proteome Sciences Plc, Rational Therapeutics, and Ribomed Biotechnologies. <\/span><\/p>\n

Request for a sample at
http:\/\/www.strategymrc.com\/report\/cancertumor-profiling-market<\/a><\/strong>
<\/strong><\/p>\n

Scope of the Report:<\/strong><\/p>\n

Applications Covered:<\/strong>
• Biomarker Discovery
• Diagnostics
• Personalized Medicine
• Prognosis
• Research Applications<\/p>\n

Technologies Covered:<\/strong>
• Fluorescence\/Chromogenic In Situ Hybridization
• Immunohistochemistry
• Microarray
• Next-Generation Sequencing
• Quantitative PCR<\/p>\n

Regions Covered:<\/strong>
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt<\/p>\n

What our report offers:<\/strong>
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements<\/span><\/p>\n

Follow us on LinkedIn: <\/strong>
<\/strong>https:\/\/www.linkedin.com\/company\/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile<\/a><\/p>\n

Follow us on Twitter:<\/strong>
<\/strong>https:\/\/twitter.com\/StratisticsMRC<\/a><\/p>\n

About Stratistics MRC<\/strong><\/p>\n

We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.<\/p>\n

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.<\/p>\n

For more information, please visit<\/strong> Stratistics Market Research Consulting Pvt Ltd<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Stratistics Market Research Consulting
Contact Person:<\/strong> James Lamb
Email:<\/strong> info@strategymrc.com
Phone:<\/strong> +1-301-202-5929
City:<\/strong> Gaithersburg
State:<\/strong> Maryland
Country:<\/strong> United States
Website:<\/strong> www.strategymrc.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Stratistics MRC, one stop shop for all your market research needs.” According to Stratistics MRC, the Global Cancer\/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-92615","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/92615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=92615"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/92615\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=92615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=92615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=92615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}